Filing Details

Accession Number:
0001179110-13-003170
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-20 18:19:35
Reporting Period:
2013-02-15
Filing Date:
2013-02-20
Accepted Time:
2013-02-20 18:19:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1452290 J Michael Warmuth 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Disposition 2013-02-19 6,452 $35.08 38,618 No 4 F Direct
Common Shares Without Par Value Disposition 2013-02-19 2,800 $34.78 35,818 No 4 S Direct
Common Shares Without Par Value Disposition 2013-02-19 266 $34.78 35,552 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2013-02-15 149,600 $0.00 149,600 $34.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
149,600 2014-02-15 2023-02-14 No 4 A Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 49,867 on 2/15/2014, 49,866 on 2/15/2015, and 49,867 on 2/15/2016.